Nerac

Information That Drives Innovation

We’re here to help with your research needs
+1 860 872 7000
Customer Access
  • Home
  • What We Do
    • Innovation Insights and Consulting Practice
    • Regulatory
    • Medical Device and Life Sciences
    • Technology Scouting and Innovation
    • Market Research
    • Intellectual Property
    • Commercialization Services for TTOs and Start-Ups
    • Critical Updates
  • Who We Serve
  • How to Engage
  • Why Nerac?
  • Meet our Team
    • Leadership Team
    • Our Analysts
    • Our Partners
  • Nerac Insights and Publications
    • Articles
    • Case Studies
    • Press Room
    • Videos
    • Webcasts
    • White Papers
  • Contact Us
You are here: Home / Archives for Nerac Insights / Articles / Stephen Buxser, Ph.D.

Drug Safety Updates – Regulations and FDA Guidance for Industry

By Stephen Buxser, Ph.D., Nerac Analyst
Originally published November 28, 2016
For drugs licensed for sale in the United States, as well as elsewhere in the world, there are requirements for periodic literature updates/reviews. This article describes the legal requirements for drug safety and efficacy reporting.
Read More

Antibiotic Resistant Bacteria – Threats and Opportunities.

By Stephen E. Buxser, Ph.D., Nerac Analyst,
Originally Published: November 6, 2015
This report looks into the issue of antibiotic resistance and the development of new antimocrobials. Read More

Keeping up with important trends: Weight Gain and Drinking Diet Soda

By Stephen E. Buxser, Ph.D., Nerac Analyst,
Originally Published: July 13th, 2015
A paper just released electronically [Fowler, et al. (2015) J. Am. Geriatr. Soc. In press. Diet soda intake is associated with long-term increases in waist circumference in a biethnic cohort of older adults: The San Antonia longitudinal study of aging.].
Read More

Which is Better, Sugar or Artificial Sweetener?

By Stephen E. Buxser, Ph.D., Nerac Analyst,
Originally Published: October 31st, 2014
Which is better, sugar or artificial sweetener? Or put another way… “regular” or “diet”?
Read more

Artificial Sweeteners: Gut Microflora, Metabolism, and Diabetes: Potential for significant and unexpected health effects

By Stephen Buxser, Ph.D, Nerac Analyst
Originally Published: October 27th, 2014
A recent article about the effects of non-caloric artificial sweeteners (NASs) on gut microflora and on gut and nutritional physiology has profound implications for the current epidemic of obesity and diabetes. Read more

The Ice Bucket Challenge and Funding of ALS Biomedical Research: A Drop in the Bucket

By John Leavitt, Ph.D., Nerac Analyst and Stephen Buxser, Ph.D., Nerac Analyst
Originally Published: August 21, 2014
For the past week we have seen a lot of giddy newscasters drench themselves with ice water eliciting cries of delight and laughter among their colleagues. Read more

New Diagnostics in Medicine – Cheap, Fast, and Accurate

By Stephen Buxser, Ph.D.
Originally Published: July 15, 2014
A major, if not the major, driver of advances in medicine is the development of better diagnostics. Read more

The Revolution in Next Generation Nucleic Acid Sequencing: How is it profoundly changing biology and medicine?

By Stephen Buxser, Ph.D. Nerac Analyst
Originally Published: July 21, 2014
A revolution is well underway in the development and application of new nucleic acid sequencing technologies. Read more

  • Case Studies
  • White Papers
  • Webcasts
  • Articles
    • Nerac Strategist
    • Energy
    • Food & Nutrition
    • Intellectual Property
    • Regulatory
    • Technology & Innovation
    • Medical Device & Healthcare
    • Pharmaceutical
    • Engineering
    • Market Research
    • Critical Alerts
    • Chemistry/Advanced Materials
  • Press Room

Click here to learn more about….

3d printing advanced materials aerospace Ask Kevin Videos biotech CFDA clinical literature evaluations commercialization strategies competitive intelligence Disruptive Technologies emerging markets energy EU MDR FDA food helga weires Industry 4.0 innovation Inspiring Next intellectual property intellectual property strategies IP market analysis market research medical device medical devices nerac Nerac client questions Nerac Strategist notified body audit open innovation Order 650 patenting strategies patent landscape pharmaceutical Post-Market Surveillance R&D regulatory regulatory compliance Robert Beinstein Rosemarie Szostak specialty chemicals Sustainable Development Goals technology scouting XcellR8
  • Facebook
  • Google+
  • LinkedIn
  • RSS
  • Twitter
  • YouTube
  • Career Opportunities
  • Privacy Policy

Copyright © 2022 Nerac · One Technology Drive · Tolland, CT 06084 · 1.860.872.7000

Sign Up for the Nerac Strategist

Like what you see? Sign up here to receive the Nerac Strategist newsletter, a compilation of analyst insights on rapidly developing industry issues, compliance challenges and commercial opportunities!
  • This field is for validation purposes and should be left unchanged.